Why the study?
Does nonfluoroscopic cryoballoon ablation improve safety and efficacy in patients with symptomatic drug resistant paroxysmal atrial fibrillation?
Does nonfluoroscopic cryoballoon ablation improve safety and efficacy in patients with symptomatic drug resistant paroxysmal atrial fibrillation?
To assess safety and efficacy of nonfluoroscopic cryoballoon ablation, 32 patients with symptomatic drug resistant paroxysmal atrial fibrillation were treated.
No takes yet. Share an insight, caveat, or question.
Кропоткин et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: